Pacific Pain and Regenerative Medicine
Pacific Pain and Regenerative Medicine is a physician-led, multi-location interventional pain management and regenerative medicine practice operating seven clinics across Southern California, serving personal injury, chronic pain, and cash-pay wellness patients.
- Company typePrivate
- Founded-
- HeadquartersIrvine, United States
- Headcount11–50
- GTM typeB2C
- OfferingServices
What Pacific Pain and Regenerative Medicine does
Pacific Pain and Regenerative Medicine is a physician-led, multi-location interventional pain management and regenerative medicine practice operating seven clinics across Southern California (Irvine, Los Angeles, Upland, Corona, Ventura, Santa Barbara, and Sherman Oaks). Founded by Dr. Hasan Badday, a Georgetown PM&R-trained, fellowship-trained interventional pain specialist, the practice delivers evidence-based pain care across spine, joint, musculoskeletal, and sports injury conditions, supplemented by regenerative modalities such as IV stem cell therapy, peptide therapy (BPC-157, TB-500, GHK-Cu, KPV), and HIFEM with radiofrequency. The clinical model emphasizes function restoration via image-guided procedures (ultrasound and fluoroscopy) rather than symptom masking, and explicitly pursues a physiatric, multi-modal treatment approach.
The practice serves three primary customer segments: personal injury patients (with over 12 years of experience coordinating medical liens and providing legal documentation for attorneys), chronic pain patients covered by commercial insurance (Aetna, Anthem Blue Cross, BCBS, Cigna, UnitedHealthcare) and government payers (Medicare, Medi-Cal), and cash-pay patients seeking regenerative, weight management, and longevity services. Revenue is generated through three streams: insurance reimbursements, cash/self-pay services (with disclosed pricing of $500 for a new patient consultation and $250 for medication refill visits), and deferred-payment medical lien arrangements tied to personal injury case settlements. Distribution is primarily through in-person clinic visits, supplemented by telehealth and a referral network comprising personal injury attorneys, primary care physicians, and orthopedic specialists.
The company is privately held with no disclosed institutional investors, funding rounds, or parent entity. It reports serving more than 100,000 patients since founding and employs a team of 45+ clinical and administrative staff, including three named interventional pain physicians (Badday, Peterson, Obadeyi), a nurse practitioner (Park), and a physician assistant (Ebilane). No AI/ML capabilities, patents, certifications, or formal partnerships are disclosed; the company's differentiation rests on physician credentials, clinical expertise in personal injury documentation, and a multi-location SoCal footprint.
Pacific Pain and Regenerative Medicine firmographics
Firmographics- Name
- Pacific Pain and Regenerative Medicine
- Legal name
- Pacific Pain & Regenerative Medicine
- Website
- https://pacificpainfree.com
- Company type
- Private
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Pacific Pain and Regenerative Medicine is a physician-led, multi-location interventional pain management and regenerative medicine practice operating seven clinics across Southern California, serving personal injury, chronic pain, and cash-pay wellness patients.
- Ownership category
- akta.pro rank
Pacific Pain and Regenerative Medicine industry classification
Industry- Product category
- Pain Management and Regenerative Medicine
- NAICS
- Other Ambulatory Health Care Services (6219)
- SIC
- Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Health Services (8000)
- akta.pro primary industry
- Pain Management Clinics (Interventional & Medical) (HLAFABAH)
- akta.pro secondary industries
- Pain Management (Spine & Musculoskeletal) (HLAKALAM), Cartilage, Bone & Musculoskeletal Regeneration (HLAAAGAH), Pain Management & Interventional Procedure Centers (HLAFAIAH)
Keywords
Where Pacific Pain and Regenerative Medicine is headquartered
LocationHeadquarters
- HQ city
- Irvine
- HQ country
- United States
- HQ region
- North America
Offices7 records
Markets served
Pacific Pain and Regenerative Medicine business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Insurance-Based Medical Services: Revenue from treating patients with commercial insurance including Aetna, Anthem Blue Cross, Blue Cross Blue Shield, Cigna, United Healthcare, Medicare, Medi-Cal, and other plans. Collects co-pays, deductibles, and insurance reimbursements.
- Cash Pay Services: Self-pay patients including those without insurance. Pricing includes new patient consultation ($500) and medication refill visits ($250). Also includes cash-pay regenerative treatments like stem cell therapy and peptide programs.
- Personal Injury Lien Services: Medical lien arrangements for personal injury cases where payment is deferred until case settlement. Coordinates with attorneys and receives payment from settlement proceeds.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | Pay-as-you-go | New Patient Consultation (Cash) |
| One time/ perpetual license | Pay-as-you-go | Medication Refill Visit (Cash) |
| Subscription | Monthly | Insurance Patients |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels5 records
Pacific Pain and Regenerative Medicine product offering
Product offeringCore offering
Pacific Pain and Regenerative Medicine is a physician-led medical practice that delivers evidence-based interventional pain management and regenerative medicine services across seven Southern California clinic locations. Its core offering combines advanced imaging-guided procedures (ultrasound and fluoroscopy), minimally invasive spine interventions, regenerative therapies (stem cells, exosomes, peptides), sports medicine, and medical weight management for patients with acute, chronic, and injury-related pain. The practice also operates a dedicated personal injury program with medical-lien support, legal documentation, and litigation assistance for patients recovering from auto accidents.
Product overview
Pacific Pain and Regenerative Medicine operates as a multi-location medical practice offering eight core services: Personal Injury Care (auto accident and injury treatment with legal documentation support), Medical Weight Management using GLP1/GLP2 medications, Peptide Therapy (BPC-157, TB-500, GHK-Cu, KPV protocols), Advanced Stem Cell Therapy (IV stem cell and exosome treatments), Comprehensive Spine Care (minimally invasive procedures including epidurals, RFA, spinal cord stimulation, kyphoplasty), Ortho/Joint Care (image-guided joint injections for all major joints), Sports Medicine (injury treatment with PRP and regenerative support), and HIFEM (electromagnetic muscle therapy). The practice is physician-led by Hasan Badday, MD, and serves patients across seven Southern California locations (Irvine, DTLA, Upland, Corona, Ventura, Santa Barbara, Sherman Oaks).
Differentiator
Problem solved
Functional benefit
Products and services
- Personal Injury Care
Quantifiable outcome
- 100K+ patients served
- +2 more outcomes
Companies that use Pacific Pain and Regenerative Medicine
Customer profileNamed customers1 record
Segments5 records
Ideal customer profiles3 records
Pacific Pain and Regenerative Medicine technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Pacific Pain and Regenerative Medicine partnerships and signals
Strategic signalScale indicators3 records
Recent moves6 records
Expansion highlights5 records
Pacific Pain and Regenerative Medicine competitors and assessment
Company assessmentBroad incumbents
- HOPCo (Healthcare Outcomes Performance Company): National musculoskeletal care and practice management platform partnering with orthopedic and pain groups. Comparable as a scaled MSK platform; HOPCo represents the strategic-partner archetype that a multi-site pain group could partner with or be acquired by.
Direct peers
- QC Kinetix: Franchised regenerative medicine clinic network focused on non-surgical orthobiologic treatments (PRP, stem cell, exosomes) for pain and joint conditions. Closely comparable on cash-pay regenerative service line and consumer-facing pain positioning.
- DISC Sports & Spine Center: Southern California-based spine, sports medicine and interventional pain practice offering minimally invasive spine procedures, orthobiologics, and sports injury care. Directly comparable as a SoCal specialty MSK practice with overlapping spine, joint and regenerative services.
- National Spine & Pain Centers: Largest independent interventional pain management group in the U.S. with a multi-state network of clinics. Most directly comparable to Pacific Pain on multi-location pain practice model, mix of interventional spine and joint procedures, and insurance-based plus self-pay revenue.
- Regenexx: Network of clinics specializing in image-guided orthobiologic injections (PRP and bone marrow concentrate) for orthopedic conditions and pain. Closely comparable on regenerative medicine focus, physician-led clinic model, and cash-pay positioning for non-surgical pain care.
- California Pain Group: California-based interventional pain management practice offering spinal injections, RFA, spinal cord stimulation and joint procedures. Comparable as a regional pain practice with overlapping clinical services.
- Pain Management Associates: Independent interventional pain management group offering spinal and joint procedures across multiple clinic sites. Comparable on multi-physician pain practice model, interventional procedure mix, and insurance/cash payer blend.
- Prospira Pain Care: Multi-physician interventional pain management group operating across multiple U.S. markets with a mix of insurance and personal-injury cases. Comparable on multi-location pain clinic structure and payer/channel mix.
Emerging players
- Next Health: Multi-location wellness and longevity clinic offering IV therapy, peptide therapy, hormone optimization and aesthetic services. Comparable on cash-pay peptide/regenerative offerings and multi-location consumer wellness model, though broader than pain.
- Stem Cell Institute: Regenerative medicine provider focused on stem cell therapies for orthopedic, neurologic and inflammatory conditions. Comparable on the regenerative-medicine positioning and stem-cell-based service offering.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
Pacific Pain and Regenerative Medicine social profiles
Digital presencePacific Pain and Regenerative Medicine financial estimates
Financial estimateRevenue estimate
Valuation estimate
Pacific Pain and Regenerative Medicine leadership team
Management profileNumber of profiles
Profiles5 records
Pacific Pain and Regenerative Medicine funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Pacific Pain and Regenerative Medicine M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Pacific Pain and Regenerative Medicine
What does Pacific Pain and Regenerative Medicine do?
Pacific Pain and Regenerative Medicine is a physician-led medical practice that delivers evidence-based interventional pain management and regenerative medicine services across seven Southern California clinic locations. Its core offering combines advanced imaging-guided procedures (ultrasound and fluoroscopy), minimally invasive spine interventions, regenerative therapies (stem cells, exosomes, peptides), sports medicine, and medical weight management for patients with acute, chronic, and injury-related pain. The practice also operates a dedicated personal injury program with medical-lien support, legal documentation, and litigation assistance for patients recovering from auto accidents.
Is Pacific Pain and Regenerative Medicine a public or private company?
Pacific Pain and Regenerative Medicine is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Pacific Pain and Regenerative Medicine founded?
Pacific Pain and Regenerative Medicine was founded in -1. It employs 11 to 50 people.
Where is Pacific Pain and Regenerative Medicine based?
Pacific Pain and Regenerative Medicine is headquartered in Irvine, United States, in the North America region.
How does Pacific Pain and Regenerative Medicine make money?
Three revenue lines are on record. Insurance-Based Medical Services are the primary driver. The others are cash Pay Services and personal Injury Lien Services.
Who are Pacific Pain and Regenerative Medicine's main competitors?
HOPCo (Healthcare Outcomes Performance Company) is listed as a broad incumbent. Direct peers are QC Kinetix, DISC Sports & Spine Center, National Spine & Pain Centers, Regenexx, California Pain Group, Pain Management Associates and Prospira Pain Care. Emerging players are Next Health and Stem Cell Institute.
Does Pacific Pain and Regenerative Medicine have an API?
No public API is recorded for Pacific Pain and Regenerative Medicine.
What industry is Pacific Pain and Regenerative Medicine in?
Pacific Pain and Regenerative Medicine's product category is Pain Management and Regenerative Medicine. Its primary akta.pro industry code is HLAFABAH, Pain Management Clinics (Interventional & Medical), with a secondary code of HLAKALAM, Pain Management (Spine & Musculoskeletal). Its NAICS code is 6219 and its SIC code is 8011.